ARCHIVES

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Opens Negotiations With Litton-Bionetics For Renewal of $10 Million Frederick Contract

March 1, 1974

White House Announces FDA Initiatives To accelerate Cancer Drug Approval

April 4, 1996

The First BRCA1 Test Hits The Market; Are Oncologists, Patients Ready?

January 26, 1996

IOM Says “Immediate Steps” Needed To Avert “Crisis” In Cancer Centers Program Funding

April 28, 1989

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

May 14, 2010

Collins Sworn In As NIH Director

September 4, 2009